Recently, enhanced expression of UBE2T has been noted in several tumors, such as breast and prostate cancers, and it serves as an attractive therapeutic target.9, 10 In addition, the results provided by Hu et al.17 The gene discussed is UBE2T; the disease is prostate carcinoma.